#PRESS LEO Pharma releases new late-breaker data for #ChronicHandEczema. Read more here: leo-pharma.com/media-center ​ #DermatologyBeyondTheSkin

#Delgocitinibcream among patients with #chronichandeczema improved signs of #eczema and reduced pain and itch, as measured by both clinician- and patient-reported outcomes. ⬇️ brnw.ch/21wMqk5

#VisualAbstract: Twice-Daily Delgocitinib Cream was Effective for Adults with Moderate-to-Severe Chronic Hand Eczema dlvr.it/TBsNkL #StudyGraphics #chronichandeczema

LEO Pharma’s Anzupgo recommended by CHMP to treat chronic hand eczema in adults dlvr.it/TBFth9 #News #Regulatory #chronichandeczema

LEO Pharma’s delgocitinib cream shows promise in phase 3 chronic hand eczema trials dlvr.it/T9vc4B #News #Research #chronichandeczema

Today is #WorldHandHygieneDay – an annual reminder of the importance of maintaining clean and healthy hands. At #LEOPharma, it is also a reminder of our commitment as a leader in medical dermatology to address the needs of people living with #ChronicHandEczema #LetsTalkAboutCHE

Today is #WorldHandHygieneDay 🌍– an annual reminder of the importance of maintaining clean and healthy hands. At #LEOPharma, May 5 ✋ is also a reminder of our commitment as a leader in medical dermatology to addressing the needs of people living with #ChronicHandEczema (CHE).

#ChronicHandEczema impacts the lives of those living with the condition, but also imposes an economic strain on society. #LEOPharma aims to forge a path with its expertise to bring solutions to the challenges of such disabling skin conditions. #CHEawarenessweek #LetsTalkAboutCHE

For people with #ChronicHandEczema, the disease causes physical discomfort and can have a considerable psychological impact. #LEOPharma is committed to advancing the standard of care for patients living with CHE. #DermatologyBeyondTheSkin #CHEawarenessweek #LetsTalkAboutCHE

The management of #ChronicHandEczema (CHE) often involves minimizing contact with potential triggers. Besides symptoms such as itch and pain, CHE can lead to functional challenges like not being able to carry out domestic chores. #CHEawarenessweek #LEOPharma #LetsTalkAboutCHE

On this #WorldSafetyAndHealthAtWorkDay, LEO Pharma – as a leader in medical dermatology – kicks off #CHEawarenessweek in recognition of #ChronicHandEczema (CHE) being one of the most common work-related diseases. Look out for more CHE posts this week. #OccupationalCHE #LEOPharma

Development and Psychometric Validation of a Patient-Reported Outcome Measure to Assess the Signs and Symptoms of #ChronicHandEczema: The Hand Eczema Symptom Diary (HESD): bitly.ws/3fYm4 #DELTA1trial #Phase3 #Itch #Delgocitinib

LEO Pharma showcases promising results from DELTA 3 trial at AAD Congress business-news-today.com/leo-pharma-sho… #LEOPharma #DELTA3Trial #Dermatology #ChronicHandEczema #InnovationInCare

#PRESS LEO Pharma presents new data to advance the standard of care for people living with #ChronicHandEczema at #AAD2024. #DermatologyBeyondTheSkin

For individuals with #ChronicHandEczema, the disease causes physical discomfort and can have a considerable psychological impact. LEO Pharma is committed to advancing the standard of care for patients living with CHE. #DermatologyBeyondTheSkin

Beyond its physical symptoms, #ChronicHandEczema (CHE) can also affect quality of life. LEO Pharma is committed to advancing the standard of care for CHE, evidenced by a comprehensive program at AAD, which includes a symposium and a range of new data on show. #AAD2024